Evidence map›Paper›PMID 32850325›Full record

ArticleFrontiers in oncology2020

Development and Validation of a Gene Signature for Prediction of Relapse in Stage I Testicular Germ Cell Tumors.

Jian-Guo Zhou, Jie Yang, Su-Han Jin, Siyu Xiao, Lei Shi, Ting-You Zhang, Hu Ma, Udo S Gaipl

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jian-Guo ZhouDepartment of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Jie YangGuangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
Su-Han JinDepartment of Orthodontics, Affiliated Stomatological Hospital of Zunyi Medical University, Zunyi, China.
Siyu XiaoDepartment of Clinical Laboratory, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Lei ShiDepartment of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Ting-You ZhangDepartment of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Hu MaDepartment of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Udo S GaiplDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GEOrelapserisk score modeltesticular germ cell tumorsThe Cancer Genome Atlas

Identifiers

PMID32850325
PMCPMC7412879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.